Novartis India Faces Stock Performance Challenges Amid Mixed Technical Indicators

Aug 19 2025 08:21 AM IST
share
Share Via
Novartis India has recently experienced a change in evaluation, influenced by its technical indicators, which show mixed signals. Despite a positive quarterly financial performance, the stock has underperformed compared to the broader market over the past year, with minimal domestic mutual fund investment indicating cautious sentiment.
Novartis India, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting changes in its underlying technical trends. The stock's technical indicators have shifted, with the MACD and KST showing mildly bearish signals on both weekly and monthly charts. Additionally, Bollinger Bands and Dow Theory also indicate a bearish stance, while daily moving averages present a mildly bullish outlook.

Despite a positive financial performance in the latest quarter, Novartis India has faced challenges in its stock performance relative to the broader market. Over the past year, the stock has returned -14.01%, significantly underperforming the BSE500 index, which recorded a decline of -1.14%. The company's return on equity stands at 13.1%, but it is trading at a premium compared to its peers, with a price-to-book value of 2.9.

Furthermore, domestic mutual funds hold a minimal stake of only 0.01%, which may suggest a cautious approach towards the stock's current valuation. While the company has shown healthy growth in operating profit, the overall market sentiment appears to be weighing on its stock performance.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via